Latest Breaking News On - பாலிசேட் உயிர் - Page 2 : comparemela.com

Leading BioSciences Closes Merger with Seneca Biopharma; Begins Trading on Nasdaq Leading BioSciences, Inc. a Carlsbad, CA-based late-stage biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications, closed its previously announced merger transaction with Seneca Biopharma, Inc. The combined, publicly traded company will operate under the name Palisade Bio, Inc., and its common stock is expected to commence trading on the Nasdaq Capital Market on April 28, 2021, under the ticker symbol “PALI.” In addition, the company has announced the closing of the previously announced private placement led by Altium Capital that included $20.0 million in cash plus the cancelation of outstanding principal and interest pursuant to the notes previously issued to the investor.

Tom hallamBiosciences incSeneca biopharma incPalisade bio incLeading biosciencesSeneca biopharmaPalisade bioNasdaq capital marketAltium capitalடோம் ஹலாம்உயிர் அறிவியல் இன்க்பாலிசேட் உயிர் இன்க்முன்னணி உயிர் அறிவியல்பாலிசேட் உயிர்நாஸ்டாக் மூலதனம் சந்தை